Search Tag: coronavirus vaccine
2021 14 Apr
The Polish government has announced that 120 000 units of Johnson&Johnson vaccine arrived in Poland on Wednesday. Despite reports of rare blood clotting in some recipients, the vaccine will be used. The European Medicines Agency approved the vaccine for use in the European Union last month. However, the Health Minister Adam Niedzielski confirmed...Read more
2020 14 Dec
A new addition to the COVID-19 Risk Tools suite by the Johns Hopkins Bloomberg School of Public Health, an online mortality calculator , assesses the risk of dying from COVID-19 in currently uninfected individuals. It has been presented in an article published in Nature Medicine (Jin et al. 2020) and is available online for interested public...Read more
2020 12 Dec
As the world's first COVID-19 mass vaccination programmes are underway in the UK, the U.S. and some other countries, a new paper (Vander Stichele et al. 2020) highlights the need for global monitoring of vaccine use (who was inoculated with which vaccine product, where and when) as well as its safety and effectiveness. You might...Read more
2020 18 Nov
Pfizer has completed the Phase 3 of its COVID-19 vaccine trial and is ready to seek authorisation for emergency use in the U.S. The vaccine is reported to be 95% effective. Two other vaccine candidates, those of Moderna and the Russian Gamaleya Research Institute, demonstrated 94.5% and 92% efficacy, respectively, but the trials are still...Read more
2020 11 Nov
According to the latest reports, the COVID-19 vaccine developed by Pfizer and BioNTech has been tested on 43,500 people in six countries and shows 90% protection within seven days after the second dose. The vaccine, which has been tested in participants in the U.S., Germany, Brazil, Argentina, South Africa and Turkey, could be a real game-changer in...Read more
2020 30 Oct
Availability of an effective vaccine is viewed as crucial in the fight against COVID-19, but researchers warn against ‘vaccine nationalism’. The latest vaccine development updates are aggregated in a new online tracker. You might also like: Grand Plans for Potential COVID-19 Vaccine Production Cost of ‘Vaccine Nationalism’...Read more
2020 08 Jun
UK-based drugmaker AstraZeneca expands its plans with regard to the COVID-19 vaccine, doubling its manufacturing capacity to 2 billion doses and securing deals with a number of partners. You might also like: EU Supports Clinical Trials During COVID-19 The vaccine, AZD1222 (previously known as ChAdOx1 nCoV-19), was developed...Read more